Harris, Trump Camps Fight for Votes Door by Door in Pennsylvania | Daybreak: Europe 10/21/2024October 21, 2024
Share Facebook Twitter LinkedIn Pinterest Email Ritu Baral, TD Cowen Sr. Biotechnology Analyst, joins ‘Closing Bell Overtime’ to talk Sarepta’s approval from the FDA for its Duchenne gene therapy and how it drove the stock to its best trading day in a year.